Serum samples from patients in the cystic fibrosis group exhibited significantly higher IgA antibody reactivities to C. difficile toxins A, B and toxin B (CCUG 20309) but not to pCDTb when compared with the healthy control and C. difficile–infected patient groups (Figure 1). This evidence concerns the gene CD79A and cystic fibrosis.